| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
C4 Therapeutics Inc (NASDAQ: CCCC)
CCCC Technical Analysis
5
| As on 9th Jun 2023 CCCC STOCK Price closed @ 3.48 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 14.28 & Strong Sell for SHORT-TERM with Stoploss of 25.76 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CCCCSTOCK Price
| Open | 3.53 | Change | Price | % |
| High | 3.75 | 1 Day | -0.06 | -1.69 |
| Low | 3.35 | 1 Week | 0.09 | 2.65 |
| Close | 3.48 | 1 Month | 0.52 | 17.57 |
| Volume | 572000 | 1 Year | -28.94 | -89.27 |
| 52 Week High 33.38 | 52 Week Low 2.96 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CCCC Daily Charts |
CCCC Intraday Charts |
Whats New @ Bazaartrend |
CCCC Free Analysis |
|
|
CCCC Important Levels Intraday
| RESISTANCE | 4.25 |
| RESISTANCE | 4.00 |
| RESISTANCE | 3.85 |
| RESISTANCE | 3.70 |
| SUPPORT | 3.26 |
| SUPPORT | 3.11 |
| SUPPORT | 2.96 |
| SUPPORT | 2.71 |
CCCC Forecast April 2024
| 4th UP Forecast | 25.62 |
| 3rd UP Forecast | 18.52 |
| 2nd UP Forecast | 14.13 |
| 1st UP Forecast | 9.74 |
| 1st DOWN Forecast | -2.78 |
| 2nd DOWN Forecast | -7.17 |
| 3rd DOWN Forecast | -11.56 |
| 4th DOWN Forecast | -18.66 |
CCCC Weekly Forecast
| 4th UP Forecast | 11.19 |
| 3rd UP Forecast | 8.72 |
| 2nd UP Forecast | 7.19 |
| 1st UP Forecast | 5.66 |
| 1st DOWN Forecast | 1.30 |
| 2nd DOWN Forecast | -0.23 |
| 3rd DOWN Forecast | -1.76 |
| 4th DOWN Forecast | -4.23 |
CCCC Forecast2024
| 4th UP Forecast | 64.74 |
| 3rd UP Forecast | 45.09 |
| 2nd UP Forecast | 32.95 |
| 1st UP Forecast | 20.81 |
| 1st DOWN Forecast | -13.85 |
| 2nd DOWN Forecast | -25.99 |
| 3rd DOWN Forecast | -38.13 |
| 4th DOWN Forecast | -57.78 |
C4 Therapeutics Inc ( NASDAQ USA Symbol : CCCC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CCCC Business Profile
C4 Therapeutics, Inc., a biopharmaceutical company, develops novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable degrader that is in preclinical stage targeting IKZF1/3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; and BRAF V600E to treat melanoma, non-small cell lung cancer, colorectal cancer, and other solid malignancies, as well as RET to treat lung cancer, sporadic medullary thyroid cancers, and other solid malignancies. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffman-La Roche Ltd.; Biogen, Inc.; and Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts. Address: 490 Arsenal Way, Watertown, MA, United States, 02472
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service